Insights into the Antimicrobial Mechanisms of a Scorpion Defensin on Staphylococcus aureus Using Transcriptomic and Proteomic Analyses

Defensins constitute a family of cationic antimicrobial peptides that act against different bacteria; however, global information regarding their antibacterial mechanisms from omics-based analyses is highly limited. In this study, transcriptomics and proteomics were used to explore the antibacterial mechanisms of defensin (BmKDfsin4) originally isolated from a scorpion on a common Gram-positive bacterium. <i>Staphylococcus aureus</i> (AB94004) was treated with BmKDfsin4 for 15, 30, or 45 min based on its ability to moderately inhibit bacterial growth for one hour. Compared with those in the control group, more than 1000 genes and nearly 500 proteins in <i>S. aureus</i> were significantly differentially expressed after BmKDfsin4 treatment. In-depth analysis revealed that BmKDfsin4 significantly upregulated bacterial ribosome-related pathways and ribosomal components. In contrast, BmKDfsin4 also significantly downregulated the synthesis and metabolism pathways of bacterial amino acids. Moreover, BmKDfsin4 inhibited the synthesis pathways of teichoic acid and peptidoglycan, which are the key components of the cell wall in <i>S. aureus</i>. Furthermore, glycolysis and other metabolic processes in <i>S. aureus</i> were markedly reduced by BmKDfsin4. Overall, the global information detected from <i>S. aureus</i> revealed the multiple antibacterial mechanisms of BmKDfsin4, which could encourage the exploration of global bacterial information from the defensin family with high degrees of sequence variability and accelerate the research and development of defensins as new antibacterial agents.